Not applicableStudy completedNCT04123678What this trial is testingDERM Health Economics StudyWho this might be right forMelanomaNon-melanoma Skin Cancer Skin Analytics Limited 700
Early research (Phase 1)Active Not RecruitingNCT05614102What this trial is testingA First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Bayer 284
Not applicableUnknownNCT06227416What this trial is testingSkin Tumor Biomarkers by Mass Spectrometry ImagingWho this might be right forSkin CancerSquamous Cell CarcinomaBasal Cell Carcinoma+1 more Bispebjerg Hospital 300
Testing effectiveness (Phase 2)WithdrawnNCT01851408What this trial is testingSorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable MelanomaWho this might be right forMelanomaRecurrent MelanomaStage III Melanoma+1 more National Cancer Institute (NCI)
Not applicableLooking for participantsNCT07201376What this trial is testingAssessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions ClinicallyWho this might be right forNon-Melanoma Skin Cancer (NMSC)Benign Skin Growth Dartmouth-Hitchcock Medical Center 125
Post-approval studies (Phase 4)UnknownNCT03313544What this trial is testingEvolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1Who this might be right forMelanomaNon-small CellLung Cancer Assistance Publique Hopitaux De Marseille 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07339176What this trial is testingIntratumoral N17350 in Advanced Solid TumorsWho this might be right forNeoplasms, Solid TumorBreast Neoplasms, Triple-NegativeSquamous Cell Carcinoma of Skin+4 more Onchilles Pharma Inc 275
Not applicableLooking for participantsNCT06887348What this trial is testingAssess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3Who this might be right forMelanomaMetastatic MelanomaAdvanced Solid Tumor+1 more Replimune Inc. 50
Early research (Phase 1)Looking for participantsNCT06066138What this trial is testingTherapeutic Drug Monitoring-Based Atezolizumab DosingWho this might be right forLocally Advanced Alveolar Soft Part SarcomaMetastatic Alveolar Soft Part SarcomaLocally Advanced Non Small Cell Lung Cancer+7 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Ended earlyNCT05219578What this trial is testingRTX-224 Monotherapy in Patients With Solid TumorsWho this might be right forNon Small Cell Lung CancerCutaneous MelanomaHead and Neck Squamous Cell Carcinoma+2 more Rubius Therapeutics 7
Not applicableStudy completedNCT00253708What this trial is testingMassage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic CancerWho this might be right forCancer Beth Israel Deaconess Medical Center 39
Not applicableStudy completedNCT03139513What this trial is testingAdult Participants With BRAF V600 Mutation-Positive Advanced Melanoma Treated With Cobimetinib (Cotellic®) During the French Early Access Program (Temporary Authorization for Use [TAU])Who this might be right forMelanoma Hoffmann-La Roche 200
Testing effectiveness (Phase 2)Study completedNCT02643303What this trial is testingTremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible CancersWho this might be right forHead and Neck Squamous Cell CarcinomaBreast CancerSarcoma+8 more Ludwig Institute for Cancer Research 58
Testing effectiveness (Phase 2)Study completedNCT03110159What this trial is testingDUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant RecipientsWho this might be right forSkin CancerNon-melanoma Skin CancerSun Damaged Skin+1 more Medical Dermatology Specialists 8
Testing effectiveness (Phase 2)Study completedNCT01134250What this trial is testingCombination Therapy of F16IL2 and Paclitaxel in Solid Tumour PatientsWho this might be right forSolid TumorBreast CancerMetastatic Melanoma+1 more Philogen S.p.A. 48
Testing effectiveness (Phase 2)Looking for participantsNCT07288203What this trial is testingLifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced MelanomaWho this might be right forMelanoma (Skin Cancer)Unresectable MelanomaMetastatic Melanoma Iovance Biotherapeutics, Inc. 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05585320What this trial is testingA Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorPancreatic AdenocarcinomaMalignant Melanoma (Cutaneous)+1 more Immuneering Corporation 209
Early research (Phase 1)Ended earlyNCT04116320What this trial is testingFocused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid TumorsWho this might be right forMelanomaBreast CancerMerkel Cell Carcinoma+10 more Craig L Slingluff, Jr 5
Not applicableLooking for participantsNCT05108298What this trial is testingImproving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN TrialsWho this might be right forBreast Cancer, NOSCNS Primary Tumor, NOSCervical Cancer, NOS+9 more Eastern Cooperative Oncology Group 400
Not applicableStudy completedNCT01662713What this trial is testingOptical Frequency Domain Imaging for Non-melanoma Skin CancersWho this might be right forNon-Melanoma Skin Cancer (NMSC) Massachusetts General Hospital 10